Extracorporeal Membrane Oxygenation After Stem Cell Transplant: Clinical Decision-Making in the Absence of Evidence
Case report of a 13-yr-old patient after autologous peripheral blood stem cell transplant for stage III neuroblastoma with sepsis and hemodynamic instability who survived to discharge after a 6-day course of extracorporeal membrane oxygenation (ECMO) support.